Hormone blockers can prolong life if prostate cancer recurs

02 Feb 2017


A National Cancer Institute study, published in the New England Journal of Medicine, found that survival of men with recurring prostate cancer was greater if radiation treatment was combined with male hormone blockers.

New York Times


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story